home All News open_in_new Full Article

Genmab’s Tivdak approved in Japan for advanced cervical cancer

Genmab’s Tivdak approved in Japan for advanced cervical cancer  Pharmaceutical Technology


today last month attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 4227461351
Add Watch Country

arrow_drop_down